Displaying 801 - 820 of 1017 results

Promoting a Basic Understanding of Chemical Threats to Skin

https://www.niams.nih.gov/grants-funding/funded-research/promoting-basic-understanding-chemical-threats

Developing medical countermeasures to protect civilians against intentional and accidental toxic chemical exposure that can lead to mass casualties is a major goal of the biodefense program at NIH. More specifically, this goal is executed by the Chemical Countermeasures Research Program (CCRP) administered by NIAID and executed in partnership with several other ICs across the NIH, including NIAMS.

Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk

https://www.niams.nih.gov/grants-funding/clinical-trials-spotlight/weight-loss-and-exercise-improve-rheumatoid-arthritis

Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to

Frequently Asked Questions for PAR-24-289 (R01) and PAR-25-230 (R21): Ancillary Studies to Ongoing Clinical Projects (Clinical Trial Not Allowed)

https://www.niams.nih.gov/grants-funding/funding-opportunities/supported-scientific-areas/PAR-ancillary-studies-faqs

Applicants with additional questions are highly encouraged to contact their Program Director . These FAQs apply to the following funding opportunities: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-24-289) Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (PAR-25-230)

Typically materials from NIAMS that are more than 5 years old will be archived.